Additional file 4. Biomarker concentrations for APOA4, CD5L and IBP3 for original immunodepletion (Imde) and new immunoaffinity (IAMS) method before and after Bland Altman adjustment. The PromarkerD r
Background: Diabetic nephropathy (DN) is a leading cause of mortality and morbidity in patients with type 1 and type 2 diabetes. The multicenter FIND consortium aims to identify genes for DN an
